Since increased sCD163 levels are observed in autoimmune diseases driven by activated macrophages17–19 and autoimmune disease is a major component of APAH, the enhanced sCD163 levels in these patients may possible be secondary to their systemic disorders, and less implicated in progression of PH and poor prognosis. This evidence concerns the gene CD163 and autoimmune disease.